Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2005 | 10-2004 | 10-2003 | 10-2002 | 10-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,400 | 66,200 | 718,700 | 278,900 | 348,600 |
| Marketable Securities | 335,300 | 434,600 | 26,700 | 500 | 73,200 |
| Receivables | 207,600 | 191,000 | 112,900 | 267,500 | 459,100 |
| Inventories | 140,400 | 97,600 | 57,100 | 94,900 | 253,600 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 107,000 |
| Other current assets | 29,600 | 22,000 | 74,100 | 0 | 0 |
| TOTAL | $854,800 | $836,100 | $1,032,200 | $686,300 | $1,305,200 |
| Non-Current Assets | |||||
| PPE Net | 220,400 | 232,500 | 175,300 | 206,800 | 614,000 |
| Investments And Advances | 12,100 | 26,800 | 19,500 | 0 | 0 |
| Intangibles | 405,500 | 273,100 | 12,800 | 0 | 140,100 |
| Other Non-Current Assets | 44,400 | 59,600 | 57,100 | 251,100 | 440,400 |
| TOTAL | $682,400 | $592,000 | $264,700 | $457,900 | $1,194,500 |
| Total Assets | $1,537,200 | $1,428,100 | $1,296,900 | $1,144,200 | $2,499,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 69,600 | 72,500 | 43,900 | 73,000 | 162,000 |
| Accrued Expenses | 108,500 | 104,000 | 72,800 | 198,300 | 229,900 |
| TOTAL | $288,800 | $302,000 | $266,800 | $397,800 | $599,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 400,000 | 400,000 | 400,000 | 10,800 | 3,000 |
| Other Non-Current Liabilities | 74,500 | 66,800 | 2,400 | 3,400 | 3,900 |
| TOTAL | $474,500 | $466,800 | $402,400 | $14,200 | $6,900 |
| Total Liabilities | $763,300 | $768,800 | $669,200 | $412,000 | $606,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,801 | 115,814 | 115,197 | 114,566 | 113,438 |
| Common Shares | 23,300 | 162,000 | 161,300 | 159,900 | 158,400 |
| Retained earnings | -622,900 | -733,600 | -750,000 | -673,300 | 471,700 |
| Other shareholders' equity | -24,400 | -19,900 | -30,500 | -27,000 | 7,200 |
| TOTAL | $773,900 | $659,300 | $627,700 | $732,200 | $1,893,400 |
| Total Liabilities And Equity | $1,537,200 | $1,428,100 | $1,296,900 | $1,144,200 | $2,499,700 |